Fig. 3
From: Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes
Stroke and Stroke + LPS exacerbate neurological deficits. A two way repeated measures ANOVA showed a significant day by treatment (p = 0.0067) and day by surgery effect (p < 0.0001). When blocking the data, day 1–3 (acute phase recovery) and day 4–6 (sub-acute phase recovery), there was a significant treatment by surgery interaction (0.0454) during the acute phase of recovery. This significant treatment by surgery interaction was lost during the sub-acute phase of recovery. Depicted are mean ± SEM for 9–10 mice/group. When SEM is not shown, it is smaller than the symbol used to depict the mean. *p < 0.05